| Ytd | -10.69% | |
| 1y | 24.49% |
| Open | 3.71 | Prev Close | 3.61 | Low | 3.54 | High | 3.72 | Mkt Cap | 1.01B |
| Vol | 977.63K | Avg Vol | 3.69M | EPS | -0.61 | P/E | -5.96 | Forward P/E | -7.37 |
| Beta | 2.16 | Short Ratio | 9.72 | Inst. Own | 82.83% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 3.30 | 200-d Avg | 3.77 | 1yr Est | 8.57 |
SANA News
Gainers P3 Health Partners (NASDAQ:PIII) shares increased by 24.1% to $15.92 during Monday's af
Sana Biotechnology, Inc. (NASDAQ: SANA - Get Free Report) has been assigned an average rating of "Mo
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or ob
Genomics is reshaping healthcare, and these three stocks - MYGN, SANA and WVE - stand out as rapid a
Sana (SANA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the compan
Peer-Reviewed Letter to the Editor Describes Updated Long-Term Findings Consistent with Initial Tri
Peer-Reviewed Letter to the Editor Describes Updated Long-Term Findings Consistent with Initial Tria
SEATTLE, July 01, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focuse
Sana Biotechnology, Inc. (SANA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or ob
SEATTLE, May 27, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused
SEATTLE , May 15, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focuse
Sana Biotechnology, Inc. (SANA) Presents at Bank of America Global Healthcare Conference 2026 Transc
SEATTLE, May 12, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused
Announced strategic collaboration with Mayo Clinic, focused on improving care in type 1 diabetes and
SEATTLE, May 05, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused
SEATTLE, April 27, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focus
Dow Jones up 200 points, Avanos Medical Inc rose on going-private deal. Big gainers include AVNS, TV
Editor’s note: The future prices of benchmark tracking ETFs, the lede, the economic data and the hea
U.S. stock futures lower, with Dow futures down 150 points. Fastenal shares dip 4% after meeting ear
IDEAYA Biosciences shares (NASDAQ: IDYA) jumped 18% in pre-market trading after announcing topline
Sana Biotechnology, Inc. (NASDAQ: SANA - Get Free Report) has earned a consensus rating of "Moderate
Sana Biotechnology, Inc. (SANA) Presents at The Citizens Life Sciences Conference 2026 Transcript
Sana Biotechnology, Inc. (SANA) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Shared 12-month clinical results of ongoing UP421 type 1 diabetes study showing that hypoimmune-modi
SEATTLE, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focuse
Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-q
Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the compa
During Friday's trading, 293 companies set new 52-week lows.
On Tuesday, 540 companies set new 52-week lows.
Tuesday's session saw 729 companies set new 52-week lows.
On Monday, 524 stocks hit new 52-week lows.
On Friday, 368 stocks hit new 52-week lows.
On Thursday, 147 companies achieved new lows for the year.
On Friday, 209 companies set new 52-week lows.
On Thursday, 105 stocks hit new 52-week lows.
During Wednesday's morning trading, 400 companies set new 52-week lows.